PLC Cross-border Life Sciences Handbook Again Recognizes WilmerHale Among Top Firms

Download IconDownload Print IconPrint

PLC Cross-border Life Sciences Handbook Again Recognizes WilmerHale Among Top Firms

Attorney News

Related Solutions

Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
Providing comprehensive solutions for the acquisition, enforcement and protection of IP.

By patenting their innovations, our clients increase the value of their intellectual property and enhance their ability to compete in the marketplace. We work with laboratory and research teams and R&D and product development groups to determine whether, when and where it is in our clients’ business and technical interests to seek patent protection. And we don’t just file patent applications. Drawing on our experience with patent litigation, corporate financings and technology transactions, we implement IP strategies that conserve resources, add measurable value and give our clients a cost-effective and commercially practical competitive edge.

We help clients obtain more than 750 US and foreign patents each year, covering innovations that span the technological spectrum, including aerospace, biochemistry, biotechnology, business methods, chemistry, computer science, fuel cells, genetics, high-speed data communication, integrated circuits, materials science, medical devices, nanotechnology, pharmaceuticals, semiconductor devices and processes, and software.

We also prepare and prosecute patent applications internationally under the Patent Cooperative Treaty and by working with a network of seasoned patent lawyers around the world. Our experience extends to appeals, interferences and opposition proceedings within the US Patent and Trademark Office, the US Court of Appeals for the Federal Circuit and the European Patent Office.

We offer clients exceptional insight in dealing with competition agencies in the United States, Europe and around the world.

The PLC Cross-border Life Sciences Handbook 2007/08 has again recognized WilmerHale as a leading law firm in the area of life sciences. The firm received an overall ranking of “highly recommended” in Life Sciences in the US, and “recognized” in England.

In the US, PLC listed the firm with the following life sciences-related rankings: “leading” in Commercial/Partnering and Corporate, “highly recommended” in Intellectual Property and in Patent Counseling, and “recommended” for Regulatory and Competition/Antitrust work. In England, WilmerHale was named as “recommended” for Competition/Antitrust and Corporate work, and was “recognized” in the Intellectual Property category.

In addition to the firm rankings, the handbook honored eight individual WilmerHale partners:

Steven Barrett – “Recognized” in USA Commercial & Partnering
Robert Barry – “Recommended” in England Intellectual Property
James Czaban – “Recommended” in USA Regulatory
William Lee – “Highly Recommended” in USA Intellectual Property
David Redlick – “Highly Recommended” in USA Corporate
Henry Wixon – “Highly Recommended” in USA Patent Counseling
Alfred Server – “Leading” in USA Commercial & Partnering
Steven Singer – “Leading” in USA Commercial & Partnering; “Highly Recommended” in USA Corporate

Lawyers and law firms recognized by PLC are categorized, in order of prestige, under “leading,” “highly recommended,” “recommended,” or “recognized.”

The PLC Cross-border Life Sciences Handbook is a comprehensive guide to the law and leading law firms and lawyers in the life sciences practice area worldwide. The reported information is gathered through extensive research and thorough interviews with clients and practitioners to identify the firms and individuals that the market considers to be most knowledgeable in the life sciences practice area. To learn more about PLC or to view any of its handbooks, please visit www.practicallaw.com.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel